Cantitate/Preț
Produs
Total produse
Vezi coșul
Predictive Approaches in Drug Discovery and Development – Biomarkers and In Vitro / In Vivo Correlations de JA Williams

Predictive Approaches in Drug Discovery and Development – Biomarkers and In Vitro / In Vivo Correlations: Wiley Series on Technologies for the Pharmaceutical Industry

Autor JA Williams
en Limba Engleză Hardback – 18 apr 2012
Practical Utility of Biomarkers in Drug Discovery and Development covers all aspects of biomarker research applied to drug discovery and development and contains state-of-the-art appraisals on the practical utility of genomic, biochemical, and protein biomarkers. Case histories and lessons from successful and unsuccessful applications of biomarkers are included along with key chapters on GLP validation, safety biomarkers and proteomics biomarkers. Regulatory agency perspectives and initiatives both in the US and internationally are also discussed.
Citește tot Restrânge

Din seria Wiley Series on Technologies for the Pharmaceutical Industry

Preț: 95526 lei

Preț vechi: 100553 lei
-5% Nou

Puncte Express: 1433
Preț estimativ în valută:
18288€ • 19009$ • 15162£

Carte tipărită la comandă

Livrare economică 05-19 februarie 25

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780470170830
ISBN-10: 0470170832
Pagini: 416
Dimensiuni: 159 x 237 x 29 mm
Greutate: 0.7 kg
Editura: Wiley
Seria Wiley Series on Technologies for the Pharmaceutical Industry

Locul publicării:Hoboken, United States

Public țintă

Pharmaceutical scientists pursing drug research and development, including management, bench–level pharmacologists, and toxicologists; Clinical pharmacologists and clinicians, ADME/Tox and pharmaceutical scientists and students; Pharmaceutical companies interested in improving decision making and reducing costs; Regulatory agencies like the US FDA and EPA, British MHRA, and other European and Japanese equivalents.

Cuprins

Notă biografică

J. Andrew Williams, PHD, is Director of Translational Oncology at Pfizer Oncology. Richard Lalonde, PharmD, is Vice President and Global Head of Clinical Pharmacology at Pfizer. Jeffrey Koup, PharmD, is a consultant for PKPD modeling and the owner of Lakeside PKPD, LLC. David D. Christ, PHD, is a consultant with SNC Partners LLC.

Descriere

Practical Utility of Biomarkers in Drug Discovery and Development covers all aspects of biomarker research applied to drug discovery and development and contains state-of-the-art appraisals on the practical utility of genomic, biochemical, and protein biomarkers.